Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation
Massachusetts General Hospital
Massachusetts General Hospital
OHSU Knight Cancer Institute
Sumitomo Pharma America, Inc.
Ohio State University Comprehensive Cancer Center
Virginia Commonwealth University